Bioharvest Sciences Inc

BHST

7.830USD

-1.020-11.53%

Close 11/06, 16:00（ET）Quotes delayed by 15 min

Bioharvest Sciences Inc's Score

Industry at a Glance

Industry Ranking

51 / 96

Overall Ranking

244 / 4615

Industry

Food & Tobacco

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

15.500

Target Price

+75.14%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bioharvest Sciences Inc Highlights

StrengthsRisks

BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 358.13% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 25.19M.

Fairly Valued

The company’s latest PE is -11.43, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 238.98K shares, increasing 36.00% quarter-over-quarter.

The company's current financial score is 6.68, which is lower than the Food & Tobacco industry's average of 7.08. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 8.52M, representing a year-over-year increase of 41.28%, while its net profit experienced a year-over-year increase of 493.89%.

Score

Industry at a Glance

Previous score

6.68

Change

0



Financials

4.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

5.94

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.04

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.25

Key Metrics

Free cash flow

No Data

The company’s current valuation score is 8.41, which is higher than the Food & Tobacco industry's average of 7.47. Its current P/E ratio is -11.43, which is -56.63% below the recent high of -4.96 and -61.56% above the recent low of -18.47.

Score

Industry at a Glance

Previous score

8.41

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 51/96

No Data

The company’s current earnings forecast score is 8.00, which is higher than the Food & Tobacco industry's average of 7.37. The average price target for Bioharvest Sciences Inc is 15.00, with a high of 18.00 and a low of 14.00.

Score

Industry at a Glance

Previous score

8.00

Change

0

Support & Resistance

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The company’s current price momentum score is 6.62, which is lower than the Food & Tobacco industry's average of 6.69. Sideways: Currently, the stock price is trading between the resistance level at 11.15 and the support level at 6.16, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.77

Change

-0.15

Support & Resistance

No Data

Institutional Confidence

Currency: USD Updated: 2025-11-06

Score

Industry at a Glance

Previous score

3.00

Change

0

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Rakib (Vivien)

3.03M

+0.72%

Greensoil Investments Management Ltd

1.42M

--

True North Advisors, LLC

21.65K

-51.23%

Magnus Financial Group LLC

70.00K

-2.42%

Ryan (David K)

39.01K

--

TD Waterhouse Canada, Inc.

12.04K

--

Binder (Anne)

8.96K

--

RBC Capital Markets Wealth Management

3.00K

--

Moreh (Bar)

1.15K

--

Osaic Holdings, Inc.

628.00

--



1

2



The company’s current risk assessment score is 2.07, which is lower than the Food & Tobacco industry's average of 5.44. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Bioharvest Sciences Inc

BHST

6.36 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Turning Point Brands Inc

TPB

8.41 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Post Holdings Inc

POST

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Andersons Inc

ANDE

8.19 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cal-Maine Foods Inc

CALM

8.12 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Fresh Del Monte Produce Inc

FDP

8.11 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment